Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,432
Closed -$1.91M 640
2026
Q1
$1.91M Buy
5,432
+2,337
+76% +$833K 0.46% 24
2025
Q4
$1.01M Buy
3,095
+1,714
+124% +$544K 0.28% 101
2025
Q3
$390K Sell
1,381
-2,829
-67% -$820K 0.09% 392
2025
Q2
$1.18M Buy
4,210
+212
+5% +$60.1K 0.27% 111
2025
Q1
$1.25M Buy
+3,998
New +$1.18M 0.37% 64
2024
Q1
Sell
-864
Closed -$249K 579
2023
Q4
$249K Sell
864
-221
-20% -$60.2K 0.18% 264
2023
Q3
$292K Sell
1,085
-3,964
-79% -$989K 0.17% 262
2023
Q2
$1.12M Buy
+5,049
New +$1.17M 0.6% 4

Other funds holding AMGN

InceptionR's AMGN Position: Q2 2026 in Review

InceptionR sold out of Amgen (AMGN) in Q2 2026, closing a stake of 5,432 shares — an estimated $1.91M sold.

InceptionR first reported a position in AMGN in Q2 2023 and held it in 8 quarters. The position peaked at $1.91M in Q1 2026. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • InceptionR reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • InceptionR sold 5,432 Amgen shares in Q2 2026, an estimated $1.91M.
  • InceptionR first reported a position in Amgen in Q2 2023 and held it in 8 quarters.
  • InceptionR's Amgen position peaked at $1.91M in Q1 2026.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.